Gretchen Harris Sperry Discusses Illinois Supreme Court Case Regarding Liability Over Drug Manufacturers" Warning Labels
In The News | 1 min read
Jan 5, 2023
In a Law360 article reporting on "Illinois Cases To Watch In 2023," Hinshaw partner Gretchen Harris Sperry discussed a case in which the Illinois Supreme Court must decide whether a woman suing a drug manufacturer over allegedly insufficient warning labels can take her claims to trial. The ruling could weaken drug makers’ ability to rely on the learned intermediary doctrine to insulate themselves from liability based on doctors' prescribing decisions in product liability failure-to-warn cases.
Sperry explained that an intermediate Illinois panel reversed the drug maker's summary judgment win, finding that the court should have applied an objective standard to determine whether a reasonable doctor in that situation would have made the same prescribing decision, rather than a subjective standard focused on whether the defendant doctor would have made the same decision with a different warning based on this patient’s condition. "From a procedural perspective, it basically turned the analysis on its head" and conflates the standard for analyzing medical malpractice claims with product liability claims, Sperry said. "It puts pharmaceutical manufacturers in an extraordinarily difficult position to write drug labels and not be able to rely on the doctors to interpret them."
Sperry described the intermediate panel's decision as "a real departure" from the analysis typically applied to patients' failure-to-warn claims against drug makers, upending decades of case law on the subject, and noted that the state high court would send a shockwave through the legal system if it backed the panel.
Read the full article (subscription required)
"Illinois Cases To Watch In 2023" was published by Law360 on January 2, 2023
Related Capabilities
Related Locations
Featured Insights

In The News
Nov 18, 2026
William Schubert: Why Client Confidentiality Reigns Supreme for Motions to Withdraw
![[Byline] Revisiting Disparate Impact Liability Under Executive Order 14281](/a/web/9w8wghM45uReApTZbaaDqe/eFisyR/examining-disparate-impact-liability-in-financial-services-under-executive-order-14281-insights.jpg)
In The News
Nov 18, 2026
[Byline] Revisiting Disparate Impact Liability Under Executive Order 14281

In The News
Nov 17, 2026
Justin Penn Examines FCRA Trends Involving “Legal vs. Factual Inaccuracy” Defense

Consumer Crossroads: Where Financial Services and Litigation Intersect
Nov 16, 2026
SCOTUS to Decide: Are Bankruptcy Stay Violations Arbitrable?

Press Release
Nov 13, 2026
Hinshaw Advises Client Safe Harbor Capital Partners in $44 Million Financing

In The News
Nov 12, 2026
Spencer Kook Authors Article Providing a Claims Manager’s Guide to Class Action Exposure

In The News
Nov 12, 2026
Mitch Chargo Discusses Cannabis M&A Implications in a Post-Rescheduling Landscape

Webinar
Nov 12, 2026
Michael Adams Presents on Navigating Ethics in the Digital Age

Event
Nov 12, 2026
Cathy Mulrow-Peattie Discusses AI and Supply Chain Cybersecurity

Healthcare Alert
Nov 11, 2026
Illinois Enacts 340B Contract Pharmacy Protections: 7 Steps Covered Entities Should Take

In The News
Nov 10, 2026
Brian Turetsky Examines How NYC’s Proposed POWER Act Could Expand Private UDAAP Claims

